← Full program

  • Spine
  • Business of Medicine

Multimodal Neuromodulation: Evolution or Escalation?

Details

Date
Friday, January 22, 2027
Time
4:00 PM – 5:30 PM
Room
Milano Ballroom III & IV
Session type
Panel Session
Schedule
See this day

About

Neuromodulation is moving from a single-device "one target, one therapy" model to an integrated approach where SCS, DRG stimulation, and PNS are selected and combined based on pain phenotype, coverage needs, and durability goals. This panel will examine how and when to deploy multimodal neuromodulation strategies in chronic pain, the evidence supporting component modalities, and how closed-loop/adaptive systems and programming approaches may reduce failures and reinterventions. The discussion will emphasize practical clinical algorithms, evidence gaps, and real-world outcomes needed to support broader adoption.

Learning objectives

  • Discuss the need for combination therapy and explain whether combining neuromodulation modalities (such as SCS, DRG, or PNS) may improve neural targeting compared with using a single approach.
  • Apply anatomical principles to guide selection and integration of SCS, DRG, and peripheral nerve stimulation in chronic pain management.
  • Identify outcomes and health-system metrics (reintervention, explanation, utilization, cost signals) that best support value-based justification of multimodal strategies.

Faculty

Presentations